PRMT5/MEP50, FLAG-Tag, His-Tag (HEK293-derived) Recombinant

Catalog #
51045
$595 *
Size: 20 µg
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

Complex of human recombinant PRMT and MEP50 proteins. Recombinant human PRMT5 (protein arginine methyltransferase 5, variant 1), encompassing amino acids 2-637(end). This construct contains an N-terminal Flag-tag. Recombinant human MEP50 (WD repeat domain 77, variant 2), encompassing amino acids 2-342(end). This construct contains an N-terminal His-tag (6xHis). The two proteins were co-expressed and affinity purified.

This product has been cited 11 times.

Synonyms
PRMT5, HRMT1L5, IBP72, JBP1, SKB1, PRMT Protein, PRMT-5
Product Info
Storage and Usage
Citations11
Species
Human
Construct
PRMT5 (FLAG-2-637(end)) / MEP50 (His-2-342(end))
Host Species/Expression System
HEK293
Purity

≥90%

Format
Aqueous buffer solution
Formulation

40 mM Tris-HCl pH 8.0, 110 mM NaCl, 2.2 mM KCl, 20% glycerol, 3 mM DTT, and 100 µg/ml FLAG peptide

MW
PRMT5: 74 kDa; MEP50: 38 kDa
Amino Acids
PRMT5: 2-637(end); MEP50: 2-342(end)
Genbank #
PRMT5: NM_006109; MEP50: NM_024102
UniProt #
O14744
Tag(s)
N-terminal FLAG-tag (PRMT5), N-terminal His-tag (MEP50)
Background

Three types of arginine methylation exist in mammalian cells: monomethylarginine (MMA), asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA). Type I PRMTs ((CARM1, PRMT1, PRMT2, PRMT3, PRMT6, and PRMT8) catalyze ADMA, while type II PRMTs (e.g. PRMTs 5 and 7) catalyze SDMA. Type II PRMTs are found to be strongly implicated in diseases like cancer. For example, PRMT5 plays a role in the repression of certain tumor suppressor genes such as RB tumor suppressors while PRMT7 overexpression is observed in breast cancer